New targets in endocrine-resistant hormone receptor-positive breast cancer. | Clin Adv Hematol Oncol;19(8): 511-521, 2021 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

New targets in endocrine-resistant hormone receptor-positive breast cancer.

Kennedy, Laura C; Mayer, Ingrid A.

Affiliation

Kennedy LC; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Mayer IA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Clin Adv Hematol Oncol ; 19(8): 511-521, 2021 Aug.

Article in En | MEDLINE | ID: mdl-34411071

Subject(s)

Breast Neoplasms; Antineoplastic Agents, Hormonal/therapeutic use; Breast Neoplasms/drug therapy; Drug Resistance, Neoplasm/drug effects; Female; Humans

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: Clin Adv Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Female / Humans Language: En Journal: Clin Adv Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Country of publication: United States